Lipoprotein Lp(a) Levels are Reduced by the Steroid Danazol

Crook, D; Sidhu, M; Donell, M O; Stevenson, JC; Seed, M

doi:10.1042/cs082034P

D Crook

Wynn Institute for Metabolic Research, London, and Departments of Chemical Pathology and Medicine, Charing Cross Hospital, London, England

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

M Sidhu

Wynn Institute for Metabolic Research, London, and Departments of Chemical Pathology and Medicine, Charing Cross Hospital, London, England

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

M O Donell

Wynn Institute for Metabolic Research, London, and Departments of Chemical Pathology and Medicine, Charing Cross Hospital, London, England

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

JC Stevenson

Wynn Institute for Metabolic Research, London, and Departments of Chemical Pathology and Medicine, Charing Cross Hospital, London, England

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

M Seed

Wynn Institute for Metabolic Research, London, and Departments of Chemical Pathology and Medicine, Charing Cross Hospital, London, England

Search for other works by this author on:

This Site

PubMed

Google Scholar

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Lipoprotein Lp(a) Levels are Reduced by the Steroid Danazol

Article PDF first page preview

Cited By

Get Email Alerts

CONNECT

EXPLORE

Lipoprotein Lp(a) Levels are Reduced by the Steroid Danazol

Article PDF first page preview

Sign in

Sign in to your personal account

Biochemical Society Member Sign in

Sign in via your Institution

Cited By

Get Email Alerts

Related Articles

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only